Amrize AG (AMRZ) Misses Q2 EPS by 37c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AMRZ Hot Sheet
Join SI Premium – FREE
Amrize AG (NYSE: AMRZ) reported Q2 EPS of $0.78, $0.37 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $3.22 billion versus the consensus estimate of $3.36 billion.
GUIDANCE:
Amrize AG sees FY2025 revenue of $11.4-11.8 billion versus consensus of $11.894 billion
For earnings history and earnings-related data on Amrize AG (AMRZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 3c
- CrossAmerica Partners (CAPL) Misses Q3 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
